Urology Cancer

Q: Prostate Cancer Facts

According to the American Cancer Society, prostate cancer is the most common cancer other than skin cancer, in American men. One in 6 men will be diagnosed with prostate cancer during his lifetime compared to 1 out of 8 women developing breast cancer Prostate cancer is the second leading cause of cancer death in men behind lung cancers

Q: Standards for Diagnosis

PSA (Prostate Specific Antigen) blood test DRE (Digital Rectal Exam) If DRE finding or PSA level is abnormal a TRUS (trans rectal ultrasound guided) biopsy is recommended Follow up for Negative biopsies is repeating the PSA test periodically

Q: Are You a Candidate for Prostate MRI and MR/Ultrasound Fusion Biopsy?

Patients with elevated Prostate-specific Antigen (PSA) level >4 Negative prior trans-rectal ultrasound-guided biopsy with continued elevation or rising PSA Positive digital rectal examination with negative trans-rectal ultrasound-guided biopsy

The Urology Cancer Center at Saint Francis Healthcare is a new specialized program designed for the diagnosis and treatment of urological cancers including both prostate and bladder cancer.

Saint Francis Healthcare offers the newest technology for the diagnosis of prostate cancer:

MRI / Ultrasound fusion – guided prostate biopsy offers a comprehensive solution with a cutting edge imaging option for many patients with elevated and/or rising PSA levels. Saint Francis Healthcare is the first to bring this powerful solution to patients in the mid-south. Prostate MRI images taken can potentially identify specific areas within the gland that are suspicious and require further evaluation. Performing this biopsy with the MRI / Ultrasound fusion is able to target the suspicious areas or lesions.

Bladder Cancer

Bladder cancer is three times more common in men than women and is the fourth most common cancer (and second most common urologic cancer) found in men in the United States. At Saint Francis Healthcare, we offer the latest technology to help detect and diagnose bladder cancer.

What is a Blue Light Cystoscopy with Cysview?

Blue Light Cystoscopy with Cysview is a technology that significantly improves the detection of nonmuscle invasive papillary cancer of the bladder as an adjunct to white light compared to traditional whitelight cystoscopy alone. Cysview (hexaminolevulinate HCl) is an imaging solution that is delivered into the bladder and is absorbed by cancerous tissue. The doctor performs the cystoscopy by using both white light and blue light. When the doctor switches to blue light, it highlights cancerous tumors and makes them more visible. Using Blue Light Cystoscopy with Cysview in conjunction with white light allows the physician to see more tumors than with standard white light cystoscopy alone

Can Anyone Get Blue-Light Cystoscopy with Cysview?

Blue-Light Cystoscopy with Cysview is recommended for anyone whose doctor suspects or knows that his or her patient has bladder cancer lesions based on a previous cystoscopy

What is a standard cystoscopy?

Standard cystoscopy is a test that allows your doctor to look directly inside your bladder with a scope. A cystoscopy may be used to help find the cause of symptoms, to treat or monitor conditions. Cystoscopy lets the doctor inspect your bladder lining very closely for any abnormal growths or suspicious areas. The entire procedure is done under standard white light.